Evaluating acute toxicity and hepatoprotective effect of Ich can thanh oral solution in a paracetamol-induced acute hepatitis mouse model
Nội dung chính của bài viết
Tóm tắt
This study investigated the acute toxicity and hepatoprotective effect of Ich can thanh oral solution in a mouse model of paracetamol-induced acute hepatitis. The acute toxicity was assessed through oral administration, and the median lethal dose (LD50) was estimated using the Litchfield-Wilcoxon method. In the paracetamol-induced acute hepatitis model, mice were randomly divided into experimental groups and pretreated orally with distilled water, silymarin (140 mg/kg), or Ich can thanh (4.8 or 9.6 mL/kg/day) for eight consecutive days. Acute liver injury was induced by oral administration of paracetamol (400 mg/kg). Forty-eight hours after induction, serum biochemical parameters, liver weight, hepatic malondialdehyde (MDA) and glutathione (GSH) levels and histopathological changes were assessed. No mortality or toxic signs at doses up to 120 mL/kg (approximately 25 times higher than the intended human dose), indicating that LD50 exceeds the highest tested dose. Additionally, Ich can thanh 4.8 mL/kg/day showed a trend towards hepatoprotection, whereas 9.6 mL/kg/day significantly reduced liver weight, decreased AST and ALT activities, increased serum albumin levels, attenuated lipid peroxidation, and improved liver histopathological compared with the model group. In conclusion, Ich can thanh, particularly at 9.6 mL/kg/day, exerts significant hepatoprotective effects in a mouse model of paracetamol-induced acute liver injury.
Chi tiết bài viết
Từ khóa
Ich can thanh oral solution, hepatoprotection, acute toxicity, paracetamol-induced acute hepatitis, Swiss mice
Tài liệu tham khảo
2. Cuñado SS, Vega MH, López ML, et al. 4CPS-228 Acute hepatitis after paracetamol poisoning: analysis of potentially influencing factors. British Medical Journal Publishing Group. 2025; 32(1).
3. Lam P, Cheung F, Tan HY, et al. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. International Journal of Molecular Sciences. 2016; 17(4): 465.
4. Porro C, Benameur T, Cianciulli A, et al. Functional and therapeutic potential of Cynara scolymus in health benefits. Nutrients. 2024; 16(6): 872.
5. Abenavoli L, Capasso R, Milic N, et al. Milk thistle in liver diseases: past, present, future. Phytotherapy Research. 2010; 24(10): 1423-1432.
6. Kim KH, Kim YH, Lee KR. Isolation of hepatoprotective phenylpropanoid from Lactuca indica. Natural product sciences. 2010; 16: 6-9.
7. Vargas-Mendoza N, Madrigal-Santillán E, Morales-González A, et al. Hepatoprotective effect of silymarin. World Journal of Hepatology. 2014; 6(3): 144-149.
8. Van den Heuvel. The international validation of a fixed-dose procedure as an alternative to the classical LD50 test. Food and chemical toxicology. (1990); 28 (7): 469-482.
9. Shi Y, Zhang L, Jiang R, et al. Protective effects of nicotinamide against acetaminophen-induced acute liver injury. International Immunopharmacology. 2012; 14(4): 530-537.
10. Hock FJ. Drug Discovery and Evaluation: Pharmacological Assays, fourth edition, Springer Reference. 2015.
11. Abbasnezhad A, Salami F, Mohebbati R. A review: Systematic research approach on toxicity model of liver and kidney in laboratory animals. Animal Models and Experimental Medicine. 2022; 5(5): 436-44.
12. Maes M, Vinken M, Jaeschke H. Experimental models of hepatotoxicity related to acute liver failure. Toxicology and Applied Pharmacology. 2016; 290: 86-97.
13. Coelho AM, Queiroz IF, Lima WG, et al. Temporal analysis of paracetamol-induced hepatotoxicity. Drug and chemical toxicology. 2023; 46(3): 472-481.
14. Bao Y, Wang P, Shao X, et al. Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver. Drug metabolism and disposition. 2020; 48(5): 326-336.
15. Turgut G, Enli Y, Kaptanoglu B, et al. Changes in the levels of MDA and GSH in mice serum, liver and spleen after aluminum administration. Eastern Journal of Medicine. 2006; 11(1-2): 7-12.
16. Okulmus C, Icil NI, Turkyilmaz O, Yildirir ZT. Clinical chemistry reference intervals for swiss albino strain mice commonly used in scientific studies. Comparative Clinical Pathology. 2025; 34(4): 567-74.
17. Anh BH, Hương TTT, Tùng PT, et al. Evaluation of the hepatoprotective activity and antioxidant role of BOGATN tablets in experimental mice. Journal of Medical Research. 2023; 164(3).
18. Anh PTV, Chung NT, Tâm TTM, et al. Evaluation of hepatoprotective and antioxidant activities of Saphia alkali K90 in the experiment. Journal of Medical Research. 2025; 197(12): 506-15.
19. Ngoc Khanh P, Katarina B, Manh Cuong N. Studies on hepatoprotective effects of Vietnamese medicinal plants. Vietnam Journal of Science and Technology. 2023; 61(5): 725-750.
20. Peng JH, Cui T, Huang F, et al. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, kupffer cell activation, and endotoxin receptors expression. The journal of pharmacology and experimental therapeutics. 2013; 344(3): 646-654.
21. He YX, Liu MN, Wu H, et al. Puerarin: a hepatoprotective drug from bench to bedside. Chinese Medicine. 2024; 19(1): 139.
22. Soleimani V, Delghandi PS, Moallem SA, et al. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytotherapy Research; 2019; 33(6): 1627-38.
23. Sanusi F. Evaluation of the Subchronic Toxicity of Curcuma longa Linn. (Tumeric) in Normal Wistar Rats. Kwara State University (Nigeria); 2019.
24. Bemidinezhad A, Zojaji SA, Taraz Jamshidi S, et al. Evaluation of acute, subacute, and subchronic toxicity of a hepatoprotective herbal formulation. Toxicology Reports; 2023; 11: 452-9.